Loading financials from SEC filings…
Auto parts · Consumer Cyclical · Fiscal year ends Dec 31
Aptiv reported revenue of $20.4B in the fiscal year ended Dec 2025, up 3.5% from the year before. Operating income was $1.2B, an operating margin of 5.8%, and net income was $165M. Operating cash flow of $2.2B less capital expenditure of $656M left free cash flow of $1.5B. Net debt was $5.9B.
Ranks among the 17 auto parts companies we cover (1st = best; for debt, the least indebted). Green = top third, red = bottom third.
Last 5 fiscal years
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 15,618 | 17,489 | 20,051 | 19,713 | 20,398 |
| Cost of revenue | 13,182 | 14,854 | 16,612 | 16,002 | 16,500 |
| Gross profit | 2,436 | 2,635 | 3,439 | 3,711 | 3,898 |
| Research & development | 1,030 | 1,120 | 1,289 | 1,097 | 1,129 |
| Selling, general & admin | 1,075 | 1,138 | 1,436 | 1,465 | 1,673 |
| Operating income | 1,189 | 1,263 | 1,559 | 1,842 | 1,184 |
| Interest expense | 150 | 219 | 285 | 337 | 361 |
| Pre-tax income | 910 | 990 | 1,337 | 2,151 | 919 |
| Income tax | 101 | 121 | −1,928 | 223 | 700 |
| Net income | 590 | 594 | 2,938 | 1,787 | 165 |
| Diluted EPS | 1.94 | 1.96 | 10.39 | 6.96 | 0.75 |
| Diluted shares | 271 | 271 | 283 | 257 | 221 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Cash & equivalents | 3,139 | 1,531 | 1,640 | 1,573 | 1,575 |
| Receivables | 2,784 | 3,433 | 3,546 | 3,261 | 1,910 |
| Inventory | 2,014 | 2,340 | 2,365 | 2,320 | 1,789 |
| Current assets | 8,436 | 7,784 | 8,247 | 7,826 | 8,745 |
| Net PP&E | 3,294 | 3,495 | 3,785 | 3,698 | 2,872 |
| Goodwill | 2,511 | 5,106 | 5,151 | 5,024 | 4,008 |
| Total assets | 18,007 | 21,884 | 24,427 | 23,458 | 23,413 |
| Payables | 2,953 | 3,150 | 3,151 | 2,870 | 1,623 |
| Deferred revenue | 0.0 | 90.0 | 93.0 | 111 | 84.0 |
| Current liabilities | 4,207 | 4,865 | 4,808 | 5,131 | 5,037 |
| Short-term debt | 8.0 | 31.0 | 9.0 | 509 | 23.0 |
| Long-term debt | 4,059 | 6,460 | 6,204 | 7,843 | 7,467 |
| Total liabilities | 9,446 | 12,790 | 12,583 | 14,373 | 13,914 |
| Shareholders' equity | 8,347 | 8,809 | 11,548 | 8,796 | 9,207 |
| Backlog (remaining obligations) | – | 135 | 217 | 194 | 172 |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating cash flow | 1,222 | 1,263 | 1,896 | 2,446 | 2,185 |
| Capital expenditure | 611 | 844 | 906 | 830 | 656 |
| Free cash flow | 611 | 419 | 990 | 1,616 | 1,529 |
| Depreciation & amortisation | 773 | 762 | 912 | 964 | 991 |
| Stock-based compensation | 87.0 | 86.0 | 115 | 120 | 139 |
| Acquisitions | 130 | 4,310 | 83.0 | 0.0 | 0.0 |
| Share buybacks | 0.0 | 0.0 | 398 | 4,104 | 397 |
| Dividends paid | 0.0 | 0.0 | – | – | – |
| Dividend per share | 0.00 | – | – | – | – |
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue growth (YoY) | – | 12.0% | 14.6% | −1.7% | 3.5% |
| Operating income growth (YoY) | – | 6.2% | 23.4% | 18.2% | −35.7% |
| EPS growth (YoY) | – | 1.0% | 430.1% | −33.0% | −89.2% |
| Gross margin | 15.6% | 15.1% | 17.2% | 18.8% | 19.1% |
| Operating margin | 7.6% | 7.2% | 7.8% | 9.3% | 5.8% |
| Net margin | 3.8% | 3.4% | 14.7% | 9.1% | 0.8% |
| Return on equityBlank when equity is negative | 7.1% | 6.7% | 25.4% | 20.3% | 1.8% |
| ROCEEBIT ÷ (assets − current liabilities) | 8.6% | 7.4% | 7.9% | 10.1% | 6.4% |
| Free cash flow margin | 3.9% | 2.4% | 4.9% | 8.2% | 7.5% |
| Cash conversion (CFO ÷ net income) | 2.07x | 2.13x | 0.65x | 1.37x | 13.2x |
| Receivable days | 65 | 72 | 65 | 60 | 34 |
| Inventory days | 56 | 57 | 52 | 53 | 40 |
| Payable days | 82 | 77 | 69 | 65 | 36 |
| Interest cover | 7.93x | 5.77x | 5.47x | 5.47x | 3.28x |
| Debt ÷ equity | 0.49x | 0.74x | 0.54x | 0.95x | 0.81x |
| Net debtDebt − cash & equivalents; excludes investments; negative = net cash | 928 | 4,960 | 4,573 | 6,779 | 5,915 |
| Current ratio | 2.01x | 1.60x | 1.72x | 1.53x | 1.74x |
Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.